Garriga, Marina http://orcid.org/0000-0001-7312-4969
Mallorquí, Andrea
Serrano, Lourdes
Ríos, José
Salamero, Manel
Parellada, Eduard
Gómez-Ramiro, Marta
Oliveira, Cristina
Amoretti, Silvia
Vieta, Eduard
Bernardo, Miquel
García-Rizo, Clemente
Funding for this research was provided by:
Instituto de Salud Carlos III (PI14/00753, CM17/00102)
Article History
Received: 14 November 2018
Accepted: 30 May 2019
First Online: 13 June 2019
Compliance with ethical standards
: The protocol was approved by the local Ethical Committee and conducted in conformity with the Declaration of Helsinki.
: Marina Garriga has received grants and served as consultant or advisor for Ferrer, Lundbeck, Janssen, Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III through a ‘Rıo Hortega’ contract (CM17/00102), FEDER, and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM).Marta Gómez-Ramiro has received grant/research/travel support from Alter, Janssen, Lundbeck, Otsuka, Pfizer, Sanofi-Aventis.Eduard Parellada has received honoraria and/or research grants from the Fondo de Investigación Sanitaria of the Spanish Ministry of Science and Innovation, MINECO, Pons Balmes Grant, Fundació la Marató de TV3 of Catalonia, Janssen-Cilag, GlaxoSmithKline, Ferrer and ADAMED.Eduard Vieta has received grants, CME-related honoraria, or consulting fees from Alexza, Almirall, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Ferrer, Forest Research Institute, Gedeon Richter, GlaxoSmith-Kline, Janssen, Janssen-Cilag, Jazz, Johnson & Johnson, Lundbeck, Merck, Novartis, Organon, Otsuka, Pfizer, Pierre-Fabre, Qualigen, Roche, Sanofi-Aventis, Schering-Plough, Servier, Shire, Solvay, Takeda, Teva, CIBERSAM, the Seventh European Framework Programme (ENBREC), the Stanley Medical Research Institute, United Biosource Corporation, and Wyeth.Miquel Bernardo has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Angelini, Casen Recordati, Eli Lilly, Janssen-Cilag, Lundbeck, Otsuka, Somatics, Takeda and has obtained research funding from the Ministry of Education, Culture and Sport, the Spanish Ministry of Economy, Industry and Competitiveness (CIBERSAM), by the Government of Catalonia, Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2017SGR1355), Foundation European Group for Research In Schizophrenia (EGRIS), and the 7th Framework Program of the European Union.Clemente García-Rizo has received honoraria/travel support from Janssen-Cilag, Lundbeck and Ferrer.The other authors do not declare any conflict of interest.